Compass Therapeutics Inc. (CMPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $139.35M
Last updated: Nov 17, 2026 at 11:04 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 39.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 29.9, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about CMPX
GNG News
All CMPX news- CMPXWedbush downgrades Compass Therapeutics (CMPX) to Neutral
UpdatedHistorical
News
CMPX Valuation
CMPX Profitability: Margins, ROIC and FCF
Compass Therapeutics (CMPX) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -49.0%
Compass Therapeutics Competitors
The companies most similar to Compass Therapeutics (CMPX) include Invivyd, Protara Therapeutics and Pyxis Oncology.
Sector: Healthcare
Companies most similar to Compass TherapeuticsCMPX Analyst Ratings
Compass Therapeutics (CMPX) has a Buy consensus from 15 analysts: 12 Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 15
- Strong Buy
- 2
- Buy
- 10
- Hold
- 3
- Sell
- 0
- Strong Sell
- 0
CMPX Bull Case vs Bear Case
Bull case
- 80.0% of CMPX's analyst ratings are Buy or Strong Buy.
Bear case
- CMPX beat EPS estimates in 25.0% of its last 8 reported quarters.
CMPX Earnings: Beat Rate and Next Report
Compass Therapeutics (CMPX) beat the EPS estimate in 2 of the last 8 quarters (25.0%). Its next report is expected on Mar 3, 2027.
- Beat rate
- 2 of 8 quarters (25.0%)
- Average surprise
- -5.3%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.15
CMPX Earnings Date
CMPX reports Mar 3, 2027. The date is estimated.
CMPX ETF Holders
GNG tracks 11 ETFs that hold CMPX. The largest weights:
- Royce Value Trust Inc (RVT), 0.14% of the fund
- State Street SPDR S&P Biotech ETF (XBI), 0.04% of the fund
- Fidelity Enhanced Small Cap Core ETF (FESM), 0.02% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), 0.02% of the fund
Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About CMPX
When does CMPX report earnings?
Compass Therapeutics Inc. (CMPX) is expected to report earnings on Mar 3, 2027.
Does CMPX pay dividends?
Compass Therapeutics Inc. (CMPX) does not currently pay a regular dividend.
What is CMPX's market cap?
Compass Therapeutics Inc. (CMPX) has a market capitalization of $139.35M with a current stock price of $0.66.
CMPX pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.